NovoCure Operating Income 2014-2023 | NVCR
NovoCure Annual Operating Income (Millions of US $) |
|
---|---|
2023 | $-233 |
2022 | $-90 |
2021 | $-44 |
2020 | $30 |
2019 | $-1 |
2018 | $-34 |
2017 | $-39 |
2016 | $-115 |
2015 | $-104 |
2014 | $-80 |
2013 | $-64 |
NovoCure Quarterly Operating Income (Millions of US $) |
|
---|---|
2023-12-31 | $-52 |
2023-09-30 | $-58 |
2023-06-30 | $-63 |
2023-03-31 | $-60 |
2022-12-31 | $-43 |
2022-09-30 | $-25 |
2022-06-30 | $-21 |
2022-03-31 | $-1 |
2021-12-31 | $-23 |
2021-09-30 | $-9 |
2021-06-30 | $-12 |
2021-03-31 | $-0 |
2020-12-31 | $12 |
2020-09-30 | $15 |
2020-06-30 | $7 |
2020-03-31 | $-3 |
2019-12-31 | $0 |
2019-09-30 | $4 |
2019-06-30 | $1 |
2019-03-31 | $-6 |
2018-12-31 | $-9 |
2018-09-30 | $-5 |
2018-06-30 | $-7 |
2018-03-31 | $-13 |
2017-12-31 | $-5 |
2017-09-30 | $-6 |
2017-06-30 | $-16 |
2017-03-31 | $-13 |
2016-12-31 | $-18 |
2016-09-30 | $-28 |
2016-06-30 | $-37 |
2016-03-31 | $-32 |
2015-12-31 | $-31 |
2015-09-30 | $-24 |
2015-06-30 | |
2015-03-31 | $-22 |
2014-12-31 | |
2014-09-30 | $-18 |
2013-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $1.360B | $0.509B |
NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $124.869B | 15.67 |
Cencora (COR) | United States | $48.051B | 19.18 |
ICON (ICLR) | Ireland | $25.434B | 24.01 |
DiDi Global (DIDIY) | China | $24.400B | 0.00 |
Avantor (AVTR) | United States | $16.238B | 23.94 |
Viatris (VTRS) | United States | $13.880B | 3.96 |
CochLear (CHEOY) | $13.776B | 0.00 | |
Revvity (RVTY) | United States | $12.539B | 21.83 |
Medpace Holdings (MEDP) | United States | $12.267B | 40.36 |
Charles River Laboratories (CRL) | United States | $11.798B | 21.50 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $11.548B | 0.00 |
Natera (NTRA) | United States | $11.205B | 0.00 |
Solventum (SOLV) | United States | $11.115B | 0.00 |
Sonic Healthcare (SKHHY) | Australia | $8.282B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
HealthEquity (HQY) | United States | $6.886B | 51.45 |
Bausch + Lomb (BLCO) | Canada | $5.197B | 19.99 |
Organon (OGN) | United States | $4.771B | 4.59 |
Doximity (DOCS) | United States | $4.444B | 33.08 |
PACS (PACS) | United States | $3.713B | 0.00 |
Sotera Health (SHC) | United States | $3.227B | 15.83 |
Surgery Partners (SGRY) | United States | $3.120B | 28.88 |
Progyny (PGNY) | United States | $3.079B | 51.68 |
GoodRx Holdings (GDRX) | United States | $2.840B | 143.80 |
Life Times (LTH) | United States | $2.783B | 30.76 |
Premier (PINC) | United States | $2.511B | 9.19 |
Teladoc Health (TDOC) | United States | $2.203B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $2.164B | 7.00 |
Agilon Health (AGL) | United States | $2.055B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $1.811B | 0.00 |
Agiliti (AGTI) | United States | $1.368B | 22.33 |
Establishment Labs Holdings (ESTA) | $1.331B | 0.00 | |
Alignment Healthcare (ALHC) | United States | $0.985B | 0.00 |
Pediatrix Medical (MD) | United States | $0.760B | 7.86 |
Embecta (EMBC) | United States | $0.594B | 3.92 |
InnovAge Holding (INNV) | United States | $0.531B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
Enhabit (EHAB) | United States | $0.503B | 45.59 |
COMPASS Pathways (CMPS) | United Kingdom | $0.492B | 0.00 |
LifeMD (LFMD) | United States | $0.482B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.434B | 0.00 |
Beauty Health (SKIN) | United States | $0.400B | 0.00 |
CareDx (CDNA) | United States | $0.391B | 0.00 |
DocGo (DCGO) | United States | $0.376B | 60.17 |
MultiPlan (MPLN) | United States | $0.371B | 0.00 |
Sera Prognostics (SERA) | United States | $0.349B | 0.00 |
ModivCare (MODV) | United States | $0.335B | 4.44 |
Sharecare (SHCR) | United States | $0.290B | 0.00 |
GeneDx Holdings (WGS) | United States | $0.289B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
Biodesix (BDSX) | United States | $0.142B | 0.00 |
So-Young (SY) | China | $0.125B | 41.83 |
Oncology Institute (TOI) | United States | $0.085B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.078B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
NeueHealth (NEUE) | United States | $0.050B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.035B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.033B | 0.00 |
Nutex Health (NUTX) | United States | $0.033B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
DermTech (DMTK) | United States | $0.021B | 0.00 |
OncoCyte (OCX) | United States | $0.021B | 0.00 |
BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
NewGenIvf Group (NIVF) | Singapore | $0.007B | 0.00 |
OpGen (OPGN) | United States | $0.007B | 0.00 |
Assure Holdings (IONM) | United States | $0.005B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |